Sistemic, a microRNA profiling firm, said this week that it has signed a deal under which NeoStem subsidiary Progenitor Cell Therapy will evaluate its stem cell-characterization technology.
According to Sistemic, Progenitor will test the applicability of its miRNA profiling system and analytical approaches for stem cell characterization.
Additional terms of the arrangement were not disclosed.